Clinical trials: Contrast Media Dosing
IV Contrast Dosing
Use of Electrical Impedence to Measure Lean Body Weight as a Determinant of the Dose of Contrast Media for Abdominal CT
There are several different methods that can be used to determine the dose of iodinated contrast material for a CT scan. These include a standard fixed dose, a dose based on total body weight, a dose based on body mass index, a…
- Trial name
- NCT02170688
- Testing
- Isovue 370, Weight calculation
- Volunteers
- 139 people
- Sponsor
- Duke University
Contrast Media Dosing
Dosing Iodinated Contrast Media According to Lean vs. Total Body Weight
The purpose of this study is to evaluate the effect of dosing iodinated contrast media according to a patient's total body weight vs. lean body weight.
- Trial name
- NCT03415997
- Testing
- Iohexol
- Where
- Canada
- Volunteers
- 239 people, healthy volunteers welcome
- Sponsor
- Nova Scotia Health Authority
Obstructive Coronary Artery Disease, Coronary Arteriosclerosis
Gadofosveset Trisodium for Heart Imaging Studies
Background: Magnetic resonance imaging (MRI) is type of imaging study that uses magnetic fields and radio waves to take pictures of the body. To help the images show up more clearly, a contrast agent is injected into a vein.
- Conditions
- Obstructive Coronary Artery Disease, Coronary Arteriosclerosis, Coronary Artery Disease (CAD)
- Trial name
- NCT01853592
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- National Institutes of Health Clinical Center (CC)
Malignant Solid Neoplasm
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
This trial studies how well iohexol works in helping doctors calculate the dose of carboplatin given to patients with cancer. Drugs used in chemotherapy, such as carboplatin, work in different ways to stop the growth of tumor…
- Trial name
- NCT03997370
- Testing
- Biospecimen Collection, Carboplatin, Iohexol
- Where
- 189 sites in United States, Puerto Rico
- Volunteers
- 350 people
- Sponsor
- NRG Oncology